Effect of rhIL-17 on the expression of TLR2 and apoptotic proteins in human neutrophils
Keywords:
PMN, rhIL-17, Bax, Mcl-1, TLR2Abstract
Introduction. Neutrophils (PMNs) apoptosis occurs involving proteins of the Bcl-2 family, which control the permeability of the outer mitochondrial membrane. Proteins of this family are regulated by various factors, among others cytokine. Early observations of their own show the relationship between increased apoptosis and expression of Toll-like receptor (TLR2) in these cells stimulated by IL-17.
The aim of the planned study was to investigate the effect of rhIL-17 on selected proteins of the Bcl-2 family, such as: the proapoptotic Bax protein and antiapoptotic Mcl-1 protein in relation to the expression of TLR2 receptor. Reference to the analysed results was to investigate the influence of fMLP on estimated parameters.
Material and method. The study was conducted on human PMN isolated from peripheral blood. Apoptosis was assessed by cytometry, and the expression of TLR2, Bax, and Mcl-1 was estimated by Western blot.
The results and conclusions. The results have shown that the enhancement of neutrophils intense apoptosis depends directly from the effect of rhIL-17 and probably indirectly on TLR2 receptor. The observed changes in the expression of Bax both under the influence of fMLP and rhIL-17 stress the important role of this protein in regulating neutrophils apoptosis.
Downloads
References
Geering B, Simon H-U. Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ. 2011;18:1457-1469.
Pereira WO, Amarante-Mendes GP. Apoptosis: a programme of cell death or cell disposal. Scan. J Immunol. 2011;73:401-407
Croker BA, O’Zdonnell JA, Nowell CJ, Metcalf D, Dewson G, Campbell KJ, Rogers KL, Hu Y, Smyth GK, Zhang J, White M. Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, Bax and inhibited by Bcl-2 and Mcl-1. PNAS. 2011;108:13135-13140
Paunel-Gorgulu A, Zornig M, Logters T, Altrichter J, Rabenhorst U, Cinatl J, Windolf J, Scholz M. Mcl-1-mediated impairment of the intrinsic apoptosis pathway in circulating neutrophils from critically patients can be overcome by Fas stimulation. J Immunol. 2009;183:6198-6206
Fulop TJ, Larbi A, Linteau A, Desgeorges S, Douziech N. The role of Mcl-1 and Bax expression alteration in the decreased rescue of human neutrophils from apoptosis by GM-CSF with aging. Ann. NY Acad. Sci. 2002;973:305-308.
Frentzel JW. Disruption of apoptotic signal pathway during glucocorticoid-induced survival of human neutrophils. Michigan State University ProQuest LLC United States Code.UMI Microform 3331909. 2008;9-21,149-151
Kakareko M, Jablonska E, Jablonski J. The influence of rhIL-17 on the expression of Toll-like receptor-2. Int. Rev. Allergol. Clin. Immunol., 2010;16:32-36.
Sabroe I, Prince LR, Jones EC, Horsburgh MJ, Foster SJ, Vogel SN. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J. Immunol.2003;170:5268-5275.
Zeman K. Metody izolacji i oceny funkcji granulocytów obojętnochłonnych. Immunol. Pol. 1990;1-2 157-170.
Zhang ZG, He QY, Liu XM, Tang XY, Chen LZ. Effect of Interleukin-17 on neutrophil apoptosis. Beijing. Da. Xue. Xue. Bao. 2006;18:305-309.
Dragon S, Saffar AS, Shan L. IL-17 attenuates the anti-apoptotic effect of GM-CSF in human neutrophils. Mol. Immunol. 2008;45:160-168.
Harter L, Mica L, Stocker R, Trentz O, Keel M. Mcl-1 correlates with reduced apoptosis in neutrophils from patients with sepsis. J. Am. Coll. Surg. 2003;197:964-973.
Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell. 2004;116:527-5540.
Into T, Nodasaka Y, Hasebe A, Okuzawa T, Nakamura J, Ohata N, Shibata K. Mycoplasmal lipoproteins induce toll-like receptor 2- and caspases-mediated cell death in lymphocytes and monocytes. Microbiol. Immunol.2002;46:265-276.
Marcinczyk M, Jablonska E, Puzewska W, Hermanowska-Szpakowicz T. Effect of rhIL-15 on TLR2 expression and apoptosis of PMN from patients with Lyme disease. Med. Dosw. Mikrobiol. 2005;57:85-91.
Pelletier M, Ratthé C, Girard D. Mechanisms involved in interleukin-15-induced suppression of human neutrophil apoptosis: role of the anti-apoptotic Mcl-1 protein and several kinases including Janus kinase-2, p38 mitogen-activated protein kinase and extracellular signal-regulated kinases-1/2. FEBS Lett. 2002;4:164-170.
Bouchard A, Ratthe C, Girard D. Interleukin-15 delays human neutrophil apoptosis by intracellular events and not via extracellular factors: role of Mcl-1 and decreased activity of caspase-3 and caspase-8. J. Leukoc. Biol. 2004;75:893-900.
Derouet M, Thomas L, Cross A, Moots RJ, Edwards SW. Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J Biol Chem. 2004;279:26915-26921
Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, Newburger PE. Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 2002; 100:1860-1868.
Hu T, Bei L, Huang Y. The relationship between fMLP induced neutrophil respiratory burst and apoptosis of neutrophil. Shi. Yan. Sheng. Wu. Xue. Bao., 1999;32:359-366.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw

This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.




